The MERS coronavirus discovered in 2012 can cause severe pneumonia, which is often fatal. So far there is no effective therapy. Scientists have now identified a cell-specific recycling mechanism, autophagy, as a new target for combating the virus. Active ingredients that promote autophagy, including approved drugs, have been able to greatly reduce the multiplication of the virus in cells. The work was published in the journal Nature Communications.
There are around 2,500 MERS cases have been reported to the World Health Organization in 27 countries; about a third of those infected died. The authors have now discovered that the MERS virus has to slow down the cellular process of autophagy in order to multiply. On the basis of this knowledge, the team identified active ingredients that boost autophagy and thus significantly inhibit virus growth in the cells.
Autophagy is a body's own recycling mechanism that cells use to break down damaged material and waste products. The remaining building blocks are then available again for the construction of new cell structures. Components of pathogens such as viruses are also recognized and disposed of as waste products through this process of "self-digestion".
A number of viruses have developed various strategies to avoid degradation. The team examined whether the MERS virus also influences the autophagy mechanism. To this end, the scientists infected cells with the pathogen under the highest safety precautions. In fact, they could see that the recycling process in MERS-infected cells was disrupted. "This result was a clear indication that the MERS pathogen benefits from a weakening of cellular recycling," explains the author.
The research team also succeeded in identifying a previously unknown molecular switch that regulates the course of autophagy: the SKP2 protein. As the scientists found, the MERS virus activates this molecular switch in order to throttle the recycling machinery and thus avoid its own degradation. The working group used these findings. They treated MERS-infected cells with various SKP2 inhibitors to stimulate the disposal process. The strategy was successful: the autophagy-inhibiting agents reduced the virus multiplication by up to 28,000 times. Among the substances tested were already approved substances, such as the niclosamide used against tapeworm diseases, which was also identified as an SKP2 inhibitor.
"Our results show that SKP2 is a promising starting point for the development of new active substances against the MERS virus - and possibly also against other autophagy-dependent viruses", explains the author. Since SKP2 inhibitors do not attack the virus directly, the authors expect a lower risk of developing resistance when used. "However, tests for the use of SKP2 inhibitors as medication are still missing in the organism. In addition, a clear risk-benefit assessment is necessary, since already approved medication can have side effects," says the virologist. In addition, the scientists will test whether SKP2 inhibitors are also active against related coronaviruses such as the SARS virus or the virus that is currently circulating in China (2019-nCoV).
https://www.charite.de/service/pressemitteilung/artikel/detail/neuer_ansatz_fuer_mers_therapie_entdeckt/
https://www.nature.com/articles/s41467-019-13659-4
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fskp2-attenuates&filter=22
Targeting autophagy to treat MERS coronavirus
- 2,871 views
- Added
Edited
Latest News
Which of the two DNA strand…
By newseditor
Posted 16 Jun
Microglia depletion prevent…
By newseditor
Posted 16 Jun
Colorectal cancer stem cell…
By newseditor
Posted 16 Jun
Paranoia in the brain
By newseditor
Posted 16 Jun
In-vitro 3D culture of func…
By newseditor
Posted 15 Jun
Other Top Stories
How one of the X chromosomes in female embryonic stem cells is sile…
Read more
Thalamus inhibition in adolescence linked to long-lasting cortical…
Read more
Gene-edited tomatoes could be a new source of vitamin D
Read more
Brain mechanism tied to age-related memory loss
Read more
No evidence of structural brain change with short-term mindfulness…
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Pathways for macrophage upt…
By newseditor
Posted 16 Jun
Common and distinct neural…
By newseditor
Posted 16 Jun
Strand-resolved mutagenicit…
By newseditor
Posted 16 Jun
Innate-like T cells in live…
By newseditor
Posted 16 Jun
Membrane to cortex attachme…
By newseditor
Posted 16 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar